Blood Testing Sample Clauses

Blood Testing. In testing blood specimens, the testing laboratory will analyze blood/serum by using thin layer chromatography, gas chromatography, enzymatic methods, EMIT methods or gas chromatography/mass spectrometry as appropriate. A "positive" finding for cannabinoids will be reported under any of the following results obtained after testing blood specimens. (a) The blood/serum contains at least two (2) and up to five (5) nanograms THC/ml and at least ten (b) The blood/serum contains at least five (5) or more nanograms THC/ml., regardless of the THC metabolite concentration. (c) The blood/serum contains twenty (20) or more nanograms THC metabolites/ml., regardless of THC concentration.

Blood Testing. In the event the designated officers, after such good faith negotiations, are not able to resolve such dispute within such ninety (90) day period, or any agreed extension thereof, a party may invoke the provisions for binding ADR as set forth in Paragraph 9 of the Settlement Agreement. Neither party shall seek recourse against the other hereunder in any court or other forum, except as permitted by Paragraph 9 of the Settlement Agreement or as may be necessary to enforce a determination made in ADR pursuant to this Article 10 and Paragraph 9 of the Settlement Agreement.

Blood Testing. In testing blood specimens, the testing laboratory will analyze blood/serum by using gas chromatography/mass spectrometry as appropriate. In probable suspicion testing, a "positive" finding for cannabinoids will be forensically reported under any of the following results obtained after testing blood specimens by gas chromatography/mass spectrometry: a. The blood/serum contains at least two (2) and up to five (5) nanograms THC/mL and at least ten (10) nanograms THC metabolites/mL. b. The blood/serum contains at least five (5) or more nanograms THC/mL, regardless of the THC metabolite concentration. c. The blood/serum contains twenty (20) or more nanograms THC metabolites/mL, regardless of THC concentration. If none of the above blood marijuana findings results are obtained, a "negative" finding shall be reported. Where other Schedule I and II drugs in blood are detected, the laboratory is to report a positive test based on a forensically acceptable positive quantum of proof. All positive test results must be reviewed by the certifying scientist and certified as accurate. All positive test results must be reviewed by the certifying scientist and certified as accurate.